B of A Securities Downgrades Outset Medical to Underperform, Lowers Price Target to $3
B of A Securities Downgrades Outset Medical to Underperform, Lowers Price Target to $3
B of A Securities將Extinal Medical的評級下調至表現不佳，目標股價下調至3
B of A Securities analyst Travis Steed downgrades Outset Medical (NASDAQ:OM) from Buy to Underperform and lowers the price target from $32 to $3.
Bof A Securities分析師特拉維斯·斯蒂德將Extinal Medical（納斯達克股票代碼：OM）的評級從買入下調至表現不佳，並將目標股價從32美元下調至3美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。